TEST BANK: LIPPINCOTT ILLUSTRATED
REVIEWS: PHARMACOLOGY 7TH EDITION
BY KAREN WHALEN PHARMD BCPS
,TEST BANK: LIPPINCOTT ILLUSTRATED
REVIEWS: PHARMACOLOGY 7TH EDITION
BY KAREN WHALEN PHARMD BCPS
TABLE OF CONTENT
CHAPTER 1: PHARMACOKINETICS
CHAPTER 2: DRUG–RECEPTOR INTERACTIONS AND PHARMACODYNAMICS
CHAPTER 3: THE AUTONOMIC NERVOUS SYSTEM
CHAPTER 4: CHOLINERGIC AGONISTS
CHAPTER 5: CHOLINERGIC ANTAGONISTS
CHAPTER 6: ADRENERGIC AGONISTS
CHAPTER 7: ADRENERGIC ANTAGONISTS
CHAPTER 8: DRUGS FOR NEURODEGENERATIVE DISEASES
CHAPTER 9: ANXIOLYTIC AND HYPNOTIC DRUGS
CHAPTER 10: ANTIDEPRESSANTS
CHAPTER 11: ANTIPSYCHOTIC DRUGS
CHAPTER 12: DRUGS FOR EPILEPSY
CHAPTER 13: ANESTHETICS
CHAPTER 14: OPIOIDS
CHAPTER 15: DRUGS OF ABUSE
CHAPTER 16: CNS STIMULANTS
CHAPTER 17: ANTIHYPERTENSIVES
CHAPTER 18: DIURETICS
CHAPTER 19: HEART FAILURE
CHAPTER 20: ANTIARRHYTHMICS
CHAPTER 21: ANTIANGINAL DRUGS
,CHAPTER 22: ANTICOAGULANTS AND ANTIPLATELET AGENTS
CHAPTER 23: DRUGS FOR HYPERLIPIDEMIA
CHAPTER 24: PITUITARY AND THYROID
CHAPTER 25: DRUGS FOR DIABETES
CHAPTER 26: ESTROGENS AND ANDROGENS
CHAPTER 27: ADRENAL HORMONES
CHAPTER 28: DRUGS FOR OBESITY
CHAPTER 29: DRUGS FOR DISORDERS OF THE RESPIRATORY SYSTEM
CHAPTER 30: ANTIHISTAMINES
CHAPTER 31: GASTROINTESTINAL AND ANTIEMETIC DRUGS
CHAPTER 32: DRUGS FOR UROLOGIC DISORDERS
CHAPTER 33: DRUGS FOR ANEMIA
CHAPTER 34: DRUGS FOR DERMATOLOGIC DISORDERS
CHAPTER 35: DRUGS FOR BONE DISORDERS
CHAPTER 36: ANTI-INFLAMMATORY, ANTIPYRETIC, AND ANALGESIC AGENTS
CHAPTER 37: PRINCIPLES OF ANTIMICROBIAL THERAPY
CHAPTER 38: CELL WALL INHIBITORS
CHAPTER 39: PROTEIN SYNTHESIS INHIBITORS
CHAPTER 40: QUINOLONES, FOLIC ACID ANTAGONISTS, AND URINARY TRACT ANTISEPTICS
CHAPTER 41: ANTIMYCOBACTERIAL DRUGS
CHAPTER 42: ANTIFUNGAL DRUGS
CHAPTER 43: ANTIPROTOZOAL DRUGS
CHAPTER 44: ANTHELMINTIC DRUGS
CHAPTER 45: ANTIVIRAL DRUGS
CHAPTER 46: ANTICANCER DRUGS
CHAPTER 47: IMMUNOSUPPRESSANTS
CHAPTER 48: CLINICAL TOXICOLOGY
, 1. WHICH DRUGS WILL GO THROUGH A PHARMACEUTIC PHASE AFTER IT IS ADMINISTERED?
A. INTRAMUSCULAR CEPHALOSPORINS
B. INTRAVENOUS VASOPRESSORS
C. ORAL ANALGESICS
D. SUBCUTANEOUS ANTIGLYCEMICS >>ANSWER: C
WHEN DRUGS ARE ADMINISTERED PARENTERALLY, THERE IS NO PHARMACEUTIC PHASE, WHICH
OCCURS WHEN A DRUG BECOMES A SOLUTION THAT CAN CROSS THE BIOLOGIC MEMBRANE.
DIF: COGNITIVE LEVEL: UNDERSTANDING (COMPREHENSION) REF: DM 3 TOP: NURSING PROCESS:
ASSESSMENT MSC: NCLEX: PHYSIOLOGICAL INTEGRITY: PHARMACOLOGICAL AND PARENTERAL
THERAPIES
2. THE NURSE IS PREPARING TO ADMINISTER AN ORAL MEDICATION AND WANTS TO ENSURE A
RAPID DRUG ACTION. WHICH FORM OF THE MEDICATION WILL THE NURSE ADMINISTER?
A. CAPSULE
B. ENTERIC-COATED PILL
C. LIQUID SUSPENSION
D. TABLET >>ANSWER: C
LIQUID DRUGS ARE ALREADY IN SOLUTION, WHICH IS THE FORM NECESSARY FOR ABSORPTION IN THE
GI TRACT. THE OTHER FORMS MUST DISINTEGRATE INTO SMALL PARTICLES AND THEN DISSOLVE
BEFORE BEING ABSORBED.
DIF: COGNITIVE LEVEL: UNDERSTANDING (COMPREHENSION) REF: DM 3 TOP: NURSING PROCESS:
NURSING INTERVENTION
MSC: NCLEX: PHYSIOLOGICAL INTEGRITY: PHARMACOLOGICAL AND PARENTERAL THERAPIES
REVIEWS: PHARMACOLOGY 7TH EDITION
BY KAREN WHALEN PHARMD BCPS
,TEST BANK: LIPPINCOTT ILLUSTRATED
REVIEWS: PHARMACOLOGY 7TH EDITION
BY KAREN WHALEN PHARMD BCPS
TABLE OF CONTENT
CHAPTER 1: PHARMACOKINETICS
CHAPTER 2: DRUG–RECEPTOR INTERACTIONS AND PHARMACODYNAMICS
CHAPTER 3: THE AUTONOMIC NERVOUS SYSTEM
CHAPTER 4: CHOLINERGIC AGONISTS
CHAPTER 5: CHOLINERGIC ANTAGONISTS
CHAPTER 6: ADRENERGIC AGONISTS
CHAPTER 7: ADRENERGIC ANTAGONISTS
CHAPTER 8: DRUGS FOR NEURODEGENERATIVE DISEASES
CHAPTER 9: ANXIOLYTIC AND HYPNOTIC DRUGS
CHAPTER 10: ANTIDEPRESSANTS
CHAPTER 11: ANTIPSYCHOTIC DRUGS
CHAPTER 12: DRUGS FOR EPILEPSY
CHAPTER 13: ANESTHETICS
CHAPTER 14: OPIOIDS
CHAPTER 15: DRUGS OF ABUSE
CHAPTER 16: CNS STIMULANTS
CHAPTER 17: ANTIHYPERTENSIVES
CHAPTER 18: DIURETICS
CHAPTER 19: HEART FAILURE
CHAPTER 20: ANTIARRHYTHMICS
CHAPTER 21: ANTIANGINAL DRUGS
,CHAPTER 22: ANTICOAGULANTS AND ANTIPLATELET AGENTS
CHAPTER 23: DRUGS FOR HYPERLIPIDEMIA
CHAPTER 24: PITUITARY AND THYROID
CHAPTER 25: DRUGS FOR DIABETES
CHAPTER 26: ESTROGENS AND ANDROGENS
CHAPTER 27: ADRENAL HORMONES
CHAPTER 28: DRUGS FOR OBESITY
CHAPTER 29: DRUGS FOR DISORDERS OF THE RESPIRATORY SYSTEM
CHAPTER 30: ANTIHISTAMINES
CHAPTER 31: GASTROINTESTINAL AND ANTIEMETIC DRUGS
CHAPTER 32: DRUGS FOR UROLOGIC DISORDERS
CHAPTER 33: DRUGS FOR ANEMIA
CHAPTER 34: DRUGS FOR DERMATOLOGIC DISORDERS
CHAPTER 35: DRUGS FOR BONE DISORDERS
CHAPTER 36: ANTI-INFLAMMATORY, ANTIPYRETIC, AND ANALGESIC AGENTS
CHAPTER 37: PRINCIPLES OF ANTIMICROBIAL THERAPY
CHAPTER 38: CELL WALL INHIBITORS
CHAPTER 39: PROTEIN SYNTHESIS INHIBITORS
CHAPTER 40: QUINOLONES, FOLIC ACID ANTAGONISTS, AND URINARY TRACT ANTISEPTICS
CHAPTER 41: ANTIMYCOBACTERIAL DRUGS
CHAPTER 42: ANTIFUNGAL DRUGS
CHAPTER 43: ANTIPROTOZOAL DRUGS
CHAPTER 44: ANTHELMINTIC DRUGS
CHAPTER 45: ANTIVIRAL DRUGS
CHAPTER 46: ANTICANCER DRUGS
CHAPTER 47: IMMUNOSUPPRESSANTS
CHAPTER 48: CLINICAL TOXICOLOGY
, 1. WHICH DRUGS WILL GO THROUGH A PHARMACEUTIC PHASE AFTER IT IS ADMINISTERED?
A. INTRAMUSCULAR CEPHALOSPORINS
B. INTRAVENOUS VASOPRESSORS
C. ORAL ANALGESICS
D. SUBCUTANEOUS ANTIGLYCEMICS >>ANSWER: C
WHEN DRUGS ARE ADMINISTERED PARENTERALLY, THERE IS NO PHARMACEUTIC PHASE, WHICH
OCCURS WHEN A DRUG BECOMES A SOLUTION THAT CAN CROSS THE BIOLOGIC MEMBRANE.
DIF: COGNITIVE LEVEL: UNDERSTANDING (COMPREHENSION) REF: DM 3 TOP: NURSING PROCESS:
ASSESSMENT MSC: NCLEX: PHYSIOLOGICAL INTEGRITY: PHARMACOLOGICAL AND PARENTERAL
THERAPIES
2. THE NURSE IS PREPARING TO ADMINISTER AN ORAL MEDICATION AND WANTS TO ENSURE A
RAPID DRUG ACTION. WHICH FORM OF THE MEDICATION WILL THE NURSE ADMINISTER?
A. CAPSULE
B. ENTERIC-COATED PILL
C. LIQUID SUSPENSION
D. TABLET >>ANSWER: C
LIQUID DRUGS ARE ALREADY IN SOLUTION, WHICH IS THE FORM NECESSARY FOR ABSORPTION IN THE
GI TRACT. THE OTHER FORMS MUST DISINTEGRATE INTO SMALL PARTICLES AND THEN DISSOLVE
BEFORE BEING ABSORBED.
DIF: COGNITIVE LEVEL: UNDERSTANDING (COMPREHENSION) REF: DM 3 TOP: NURSING PROCESS:
NURSING INTERVENTION
MSC: NCLEX: PHYSIOLOGICAL INTEGRITY: PHARMACOLOGICAL AND PARENTERAL THERAPIES
